BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1827983)

  • 1. The effects of short- and long-term treatment with an ACE-inhibitor in rats with myocardial infarction.
    Pinto YM; van Wijngaarden J; van Gilst WH; de Graeff PA; Wesseling H
    Basic Res Cardiol; 1991; 86 Suppl 1():165-72. PubMed ID: 1827983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
    Westendorp B; Schoemaker RG; Buikema H; de Zeeuw D; van Veldhuisen DJ; van Gilst WH
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):27-32. PubMed ID: 15136971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
    Ambrosioni E; Borghi C; Magnani B
    N Engl J Med; 1995 Jan; 332(2):80-5. PubMed ID: 7990904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
    Borghi C; Ambrosioni E;
    Am Heart J; 2007 Mar; 153(3):445.e7-14. PubMed ID: 17307427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
    van Wijngaarden J; Pinto YM; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
    Cardiovasc Res; 1991 Nov; 25(11):936-42. PubMed ID: 1813122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
    Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA
    Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation.
    van Wijngaarden J; Monnink SH; Bartels H; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
    J Cardiovasc Pharmacol; 1992 May; 19(5):741-7. PubMed ID: 1381772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ACE inhibitors after myocardial infarction: close-up on zofenopril].
    Teyssedou A
    Ann Cardiol Angeiol (Paris); 2007 Jun; 56(3):137-44. PubMed ID: 17482555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of delayed intervention with ACE-inhibitor therapy on myocyte hypertrophy and growth of the cardiac interstitium in the rat model of myocardial infarction.
    McDonald KM; Chu C; Francis GS; Carlyle W; Judd DL; Hauer K; Hartman M; Cohn JN
    J Mol Cell Cardiol; 1997 Dec; 29(12):3203-10. PubMed ID: 9441827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial.
    Borghi C; Cicero AF; Bacchelli S; Esposti DD; Ambrosioni E;
    Fundam Clin Pharmacol; 2009 Oct; 23(5):641-8. PubMed ID: 19656211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of enalapril treatment on the sensitivity of cardiopulmonary reflexes in rats with myocardial infarction.
    Andrade TU; Pinto VD; Medeiros AR; Abreu GR; Moysés MR; Sampaio KN; Bissoli NS
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):606-11. PubMed ID: 17581216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats.
    Richer C; Mulder P; Fornes P; Domergue V; Heudes D; Giudicelli JF
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):147-56. PubMed ID: 1383624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
    Buikema H; Monnink SH; Tio RA; Crijns HJ; de Zeeuw D; van Gilst WH
    Br J Pharmacol; 2000 Aug; 130(8):1999-2007. PubMed ID: 10952693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
    J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral treatment with probucol in a pharmacological dose has no beneficial effects on mortality in chronic ischemic heart failure after large myocardial infarction in rats.
    Betge S; Lutz K; Roskos M; Figulla HR
    Eur J Pharmacol; 2007 Mar; 558(1-3):119-27. PubMed ID: 17210150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
    Xia QG; Reinecke A; Dorenkamp M; Storz C; Bitterling H; Penz S; Cleutjens J; Daemen MJ; Simon R; Unger T
    Acta Pharmacol Sin; 2004 Jun; 25(6):763-8. PubMed ID: 15169629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.